Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Azenta Launches the BioArc™ Ultra, a Breakthrough, Automated Solution for Efficient, Eco-Friendly Ultracold Sample Management
Monday, February 05, 2024Azenta Inc today announced the launch of the BioArc Ultra a breakthrough automated solution for highdensity ecofriendly ultracold sample management designed to provide a new level
Showcase on Lab Automation Instruments and Consumables on Display at SLAS2024 International Conference and Exhibition
Monday, February 05, 2024Azenta Life Sciences has announced that it will display a range of productivityenhancing consumables instruments and automated sample storage products at SLAS in Boston
Atara Biotherapeutics and Pierre Fabre Laboratories Release Phase 3 ALLELE Tab-cel® Data
Saturday, February 03, 2024Atara Biotherapeutics Inc a leader in Tcell immunotherapy leverages its novel allogeneic EpsteinBarr virus Tcell platform to develop transformative therapies for patients with cancer and autoimmune diseases
Windtree Renews Agreement with Chang Gung University for Scientific Collaboration to Further SERCA2a Research
Friday, February 02, 2024Windtree Therapeutics Inc a biotechnology company focused on advancing latestage interventions for critical cardiovascular disorders today announced that it has renewed its partnership
Sandoz Launches First and Only Biosimilar for Multiple Sclerosis, Tyruko® (Natalizumab), in Germany
Thursday, February 01, 2024Sandoz the global leader in generic and biosimilar medicines today announces the launch of Tyruko in Germany from February Developed by Polpharma Biologics Tyruko is the first and only
BioNTech and DualityBio Receive FDA Fast Track Designation for Innovative Antibody-Drug Conjugate Candidate BNT325/DB-1305
Thursday, February 01, 2024BioNTech SE and Duality Biologics Co Ltd today announced that the US Food and Drug Administration has granted Fast Track Designation to BNTDB The status applies to the treatment of patients
Vaxxinity Announces Research Collaboration on Active Immunotherapies for Neurodegenerative Diseases with University of Florida
Wednesday, January 31, 2024Vaxxinity Inc a US company pioneering the development of a new class of medicines today announced a research collaboration with the University of Floridas Center for Translational Research in Neurodegenerative Disease
AVROBIO and Tectonic Therapeutic Announce Merger
Wednesday, January 31, 2024AVROBIO Inc and Tectonic Therapeutic Inc a privatelyheld biotechnology company developing GPCR targeted therapeutic proteins cofounded by Timothy A Springer and Andrew C Kruse of Harvard Medical School today announced that the companies have entered...
Astellas Announces Strategic Collaboration with Mass General Brigham
Wednesday, January 31, 2024Astellas Pharma Inc announced today that it has entered into a strategic collaboration with Mass General Brigham that is focused on translational medicine and early development to establish an integrated approach to scientific advancement and clinica...
Takeda's HYQVIA® with ENHANZE® Granted European Approval for CIDP Maintenance Therapy
Tuesday, January 30, 2024Halozyme Therapeutics Inc today announced that Takeda received European Commission approval for HYQVIA coformulated with Halozymes ENHANZE drug delivery technology
